Plant polyphenols show promise in combating aging, supporting mitochondrial health and reducing inflammation, potentially improving quality of life for seniors.
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Astellas Pharma president and CEO Naoki Okamura Astellas Pharma has agreed to acquire Iveric Bio for approximately $5.9 billion, the companies said today, in a